Le Lézard
Classified in: Health
Subject: SVY

Global Molecular Diagnostic Testing Market 2016-2021 - Expected High Growth in Molecular Infectious Disease Testing, Molecular Cancer Testing & Others


DUBLIN, Jan. 19, 2018 /PRNewswire/ --

The "Expected High Growth Market Segments in Molecular Diagnostic Testing" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.

This report details the highest revenue growth areas of molecular testing, as considered by manufacturers of IVD instruments, reagents and supplies. The report covers both high-growth product segments and regional markets of significance.

Expected High Growth Market Segments in Molecular Diagnostic Testing Provides:

Clinical molecular diagnostics refer to in vitro diagnostic (IVD) tests used in patient health care that detect, quantify or characterize nucleic acid analytes, whether pathogenic nucleic acid, patient DNA or patient RNA. As an IVD market, molecular diagnostics refer to the relevant test kits, other reagents and instruments that are used for clinical testing in settings that include reference laboratories, independent labs, hospital labs, other centralized clinical labs and near-patient testing sites such as clinics and physician offices.

The report also covers Inherited disease diagnostics - diagnosis of rare genetic diseases andother inherited traits including pharmacodiagnostic (pharmacokinetic) traits;major area of application is thrombophilia markers and anticoagulant response markers.

Coverage in this report includes:

Key Topics Covered:

1: Executive Summary

Introduction
Molecular Diagnostic Technologies
Molecular Diagnostics in Healthcare

HIGH GROWTH AREAS OF MOLECULAR DIAGNOSTICS
HIGH-GROWTH REGIONAL MARKETS

2: Analysis: High-Growth Markets For Molecular Diagnostics

HIGH REVENUE GROWTH MOLECULAR TESTING AREAS IDENTIFIED
High Growth Categories in the Infectious Disease Molecular Diagnostics Market Market Size in 2016 and Forecast to 2021
High-Growth Regions for Infectious Disease Diagnostics Market (2016-2021)
High Growth Infectious Disease Market Area
High Growth Regions, NAT Blood Screening Market Market Size 2016 and Forecast to 2021
High Growth Cancer Market Area
High Growth Cancer Testing Areas, Market Size 2016 and Forecast 2021
Molecular Cancer Testing High Growth Regions
High Growth Cancer Testing Regional Markets
Other Molecular Testing High-Growth Areas, Market Size 2016 and Forecast 2021
High Growth Regional Markets for Other Testing
High-Growth Regional Markets for Other Molecular Diagnostics Testing

For more information about this report visit https://www.researchandmarkets.com/research/2mzst5/global_molecular?w=5


Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: